Clinical trial

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

NCT07189455

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-12-12

PhasePHASE3

Study timeline

Study start (actual)2025-12-12Date precision: day

Registry last updated2026-01-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small-cell Lung Cancerunresolved

Interventions

ZG006DRUG

TopotecanDRUG · verified · RxNorm: topotecan

Sponsors & collaborators

Suzhou Zelgen Biopharmaceuticals Co.,Ltdlead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07189455 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.